NeuroPace, Inc. Stock Analysis & AI Score
NeuroPace, Inc. (NPCE) has an ST Score of 49.2 (C+), driven by its Growth (B) and held back by its Profitability (C-). Analysts rate it Buy with a $20.25 price target (+45.0% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
NeuroPace, Inc. (NPCE) has an ST Score of 49.2 (C+), driven by its Growth (B) and held back by its Profitability (C-). Analysts rate it Buy with a $20.25 price target (+45.0% upside).
- Strongest
- GrowthB
- Weakest
- ProfitabilityC-
All factor grades
- GrowthB
- ForecastB
- ValuationB-
- MomentumB-
- Financial StrengthC
- ProfitabilityC-
- Piotroski3/9
Contact
NPCE stock: frequently asked questions
What is NPCE's ST Score?
NeuroPace, Inc. (NPCE) has an ST Score of 49.2 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is NPCE a buy, hold, or sell?
Analysts rate NPCE a Buy, with a price target of $20.25 (+45.0% vs the current price). Our ST Score grades it C+ (49.2/100). The ST Score is a data-driven signal, not a recommendation.
What are NPCE's factor grades?
Valuation B-, Profitability C-, Financial Strength C, Momentum B-, Growth B, Forecast B.
What is NPCE's valuation grade?
NeuroPace, Inc. (NPCE) earns a valuation grade of B-, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is NPCE's growth grade?
NeuroPace, Inc. (NPCE) earns a growth grade of B, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is NPCE's profitability grade?
NeuroPace, Inc. (NPCE) earns a profitability grade of C-, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is NPCE's financial strength grade?
NeuroPace, Inc. (NPCE) earns a financial strength grade of C, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for NPCE?
The average analyst price target for NeuroPace, Inc. (NPCE) is $20.25 from 10 analysts, which is +45.0% versus the recent price of $13.97.
What is NPCE's Piotroski score?
NeuroPace, Inc. (NPCE) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.